NCT05576051 To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting. Status COMPLETED Phase N/A
NCT05574010 A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) Status TERMINATED Phase PHASE1/PHASE2
NCT05573555 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05572567 Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT05572450 Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain Status COMPLETED Phase NA
NCT05569928 In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects Status UNKNOWN Phase NA
NCT05568719 Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively Status RECRUITING Phase PHASE3
NCT05568407 A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer Status TERMINATED Phase N/A
NCT05567952 A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir Status COMPLETED Phase PHASE2
NCT05567887 A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT05565391 A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma Status COMPLETED Phase N/A
NCT05560555 Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045. Status COMPLETED Phase N/A
NCT05554237 A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People. Status COMPLETED Phase PHASE1
NCT05553522 Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer Status TERMINATED Phase PHASE1
NCT05549505 A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery Status COMPLETED Phase PHASE2